Systemic treatment in adult uterine sarcomas.
Loading...
Embargo End Date
ICR Authors
Authors
Desar, IME
Ottevanger, PB
Benson, C
van der Graaf, WTA
Ottevanger, PB
Benson, C
van der Graaf, WTA
Document Type
Journal Article
Date
2018-02
Date Accepted
2017-12-12
Abstract
Uterine sarcomas (US) are rare mesenchymal tumours of the uterus and are divided mainly into uterine leiomyosarcoma (uLMS), low grade endometrial stromal sarcoma (LG-ESS), high grade endometrial stromal sarcoma (HG-ESS), adenosarcomas and high grade undifferentiated sarcoma (HGUS). US are often high-grade tumours with a high local recurrence rate and metastatic risk. We here discuss the current standard of care and knowledge of systemic therapy for adult uterine sarcomas, in particular uLMS, LG-ESS, HG-ESS and HGUS, in both the adjuvant as well as the metastatic setting.
Citation
Critical reviews in oncology/hematology, 2018, 122 pp. 10 - 20
Source Title
Publisher
ISSN
1040-8428
eISSN
1879-0461
Collections
Research Team
Clinical and Translational Sarcoma